Evercore ISI notes that New Star quality ratings for Medicare Advantage plans went live on the Plan Finder, visible to seniors currently making their plan selections for 2024 but more importantly affecting reimbursement levels and relative competitiveness for the 2025 plan year. Overall, as expected, star ratings stabilized more for 2025 post normalizing last year, the firm says. CVS (CVS), with 85% of enrollment now in 4-plus star contracts is the “big winner.” Other gainers in line with industry include UnitedHealth (UNH) and Cigna (CI), while low single digit decliners include Humana (HUM) and Centene (CNC), with the biggest decliner being Elevance Health (ELV).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVS:
- Rite Aid (NYSE:RAD) Files for Bankruptcy; Succumbs to Opioid Lawsuits
- CVS says 87% of Aetna MA members are in 2024 MAPD plans rated 4+ stars
- CVS Health says 4+ Star Medicare Advantage plans to increase
- CVS pulled PR suggesting Stars setback rectified, says Deutsche Bank
- CVS Health says ‘do not have knowledge of final 2024 Star ratings’
